Gradual cessation of proton pump inhibitor (PPI) treatment may prevent rebound acid secretion, measured by the alkaline tide method, in dyspepsia and reflux patients

Medical Hypotheses

Volumn 77, Issue 3, 2011, Pages 451-452

  Niv, Yaron ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CARBONATE DEHYDRATASE; CARBONIC ACID; ESOMEPRAZOLE; HYDROXYL GROUP; PROTON PUMP INHIBITOR;

ARTICLE; BLOOD; DRUG WITHDRAWAL; DYSPEPSIA; GASTRIC SUCTION; GASTROESOPHAGEAL REFLUX; GRADUAL DRUG CESSATION; HUMAN; HYPERGASTRINEMIA; RECURRENT DISEASE; STOMACH ACID SECRETION; URINE PH;

DRUG ADMINISTRATION SCHEDULE; DYSPEPSIA; GASTRIC ACID; GASTROESOPHAGEAL REFLUX; HUMANS; PROTON PUMP INHIBITORS; RECURRENCE; SECRETORY RATE;

EID: 80051817299     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.06.007     Document Type: Article

References (22)

1. McCarthy D.M. Adverse effects of proton pump inhibitor drugs: clues and conclusions. Curr Opin Gastroenterol 2010, 26:624-631.
2. Thomson A.B.R., Sauve M.D., Kassam N., Kamitakahara H. Safety of the long-term use of proton pump inhibitors. World J Gastroenterol 2010, 16:2323-2330.
3. Waldum H.L., Qvigstad G., Fossmark R., et al. Rebound hypersecretion of acid from a physiological, pathophysiological and clinical point of view. Scand J Gastroenterol 2010, 45:389-394.
4. Remer C., Sondegard B., Hilsted L., Blytzer P. Proton pump inhibitor therapy induces acid related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology 2009, 137:80-87.
5. Juul-Hansen P., Rydning A. Clinical and pathophysiological consequences of on-demand treatment with PPI in endoscopy-negative reflux disease. Is rebound hypersecretion of acid a problem?. Scand J gastroenterol 2011, 46:398-405.
6. Wada Y., Ito M., Takata S., et al. Little necessity of acid inhibition against proton pump inhibitor rebound effects and prior Helicobacter pylori eradication therapy in gastric ulcer patients: a randomized prospective study. Hepatogastroenterology 2009, 56:624-628.
7. Niklasson A., Lindstrom L., Simren M., et al. Dyspeptic symptom development after discontinuation of proton pump inhibitor: a double-blind placebo-controlled trial. Am J Gastroenterol 2010, 105:1531-1537.
8. Waldum H.L., Arnestad J.S., Brenna E., et al. Marked increase in gastric acid secretory capacity after omeprazole treatment. Gut 1996, 39:649-653.
9. Gillen D., Wirz A.A., Ardill J.E., et al. Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status. Gastroenterology 1999, 116:239-247.
10. Sharma B., Axelsson M., Pounder R.P., et al. Acid secretory capacity and plasma gastrin concentration after administration of omeprazole to normal subjects. Alimentary Pharmacol Ther 1987, 1:67-76.
11. Rune S.J. The metabolic alkalosis following aspiration of gastric acid secretion. Scand J Clin Lab Invest 1965, 17:305-310.
12. Rune S.J. Comparison of the rates of gastric acid secretion in man after ingestion of food and after maximal stimulation with histamine. Gut 1966, 7:344-350.
13. Johnson C.D., Rai A.S. Urine acid output as a test of completeness of vagotomy. Br J Surg 1990, 77:417-420.
14. Niv Y. Test meal-induced urinary alkaline tide - a repeatable phenomenon that is abolished after vagotomy. Isr J Med Sci 1992, 28:97-98.
15. Moore E.W. The alkaline tide. Gastroenterology 1967, 52:1052-1054.
16. Gleeson D. Acid-base transport systems in gastrointestinal epithelia. Gut 1992, 33:1134-1145.
17. Niv Y., Abu-Avid S., Newman G. Further applications of blood gas analysis to gastric acidity determination. Clin Chim Acta 1993, 215:9-19.
18. Ahmad A. Abolition of postprandial alkaline tide after vagotomy and its use as a screening test in the assessment of vagotomy. Br J Surg 1986, 73:917-919.
19. Niv Y., Asaf V. Abolition of postprandial alkaline tide in arterialized venous blood of duodenal ulcer patients with cimetidine and after vagotomy. Am J Gastroenterol 1995, 90:1135-1137.
20. Niv Y., Vardi I. Calcium channel blocker decreases test meal-stimulated alkaline tide: a role for extracellular calcium in gastric acid secretion. Isr J Med Sci 1995, 31:215-217.
21. Regev A., Drori R., Fraser G., Niv Y. Abolition of test meal-stimulated alkaline tide using the carbonic anhydrase inhibitor acetazolamide. IMAJ 2001, 3:247-250.
22. El-Omar E.M., Banerjee S., Wirz A., et al. The Glasgow Dyspepsia Severity Score - a tool for the global measurement of dyspepsia. Eur J Gast Hepatol 1996, 8:967-971.